Zealand’s obesity drug shouldn’t disrupt Novo Nordisk-Eli Lilly leadership: Mizuho’s Jared Holz

February 27, 2024
Zealand’s obesity drug shouldn’t disrupt Novo Nordisk-Eli Lilly leadership: Mizuho’s Jared HolzZealand’s obesity drug shouldn’t disrupt Novo Nordisk-Eli Lilly leadership: Mizuho’s Jared Holz
Share This

Jared Holz, Mizuho Americas, joins ‘Fast Money’ to talk obesity drugmakers after a new study out of Zealand Pharma analyzed the impact of GLP-1s on liver disease.

Latest Mizuho News

See all news
Graig Suvannavejh: ASCO is one of the highlights of our year in biotech

Graig Suvannavejh: ASCO is one of the highlights of our year in biotech

May 29, 2026
Mizuho Financial Group launches strategic technology and operations center in Pune

Mizuho Financial Group launches strategic technology and operations center in Pune

May 21, 2026
A lot of concern around consumer spending ahead of retail earnings, says Mizuho’s Bellinger

A lot of concern around consumer spending ahead of retail earnings, says Mizuho’s Bellinger

May 19, 2026

Mizuho news from around the globe

 Mizuho Global News
back-to-top-blue